Key Facts Surrounding This News Item
- TLRY had returned 0.00% year-to-date leading up to today’s news, versus a +9.26% return from the benchmark S&P 500 during the same period.
More Info About Tilray, Inc. – Class 2 Common Stock (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. was founded in 2018 and is based in Nanaimo, Canada. View our full TLRY ticker page with ratings, news, and more.